Evolus EOLS Current portion of contingent milestone payment

Current portion of contingent milestone payment at other companies

Ligand PharmaceuticalsLGND

$277K-81.3%

TIC Solutions TIC

$33.58M+97.2%

LKQLKQ

$532M-4.7%

Biglari Holdings Inc.BH

$12.61M-16.3%

PENN Entertainment, Inc.PENN

$46.3M+5.2%

Distribution Solutions Group, Inc.DSGR

$20.91M+12.0%

Other financials

Income statement

See full

Revenue$73.1M+6.7%

Gross profit$48.9M+4.8%

Operating income-$6.8M+54.9%

Net income-$10.7M+43.5%

EPS (diluted)-$0.16+46.7%

Balance sheet

See full

Cash & equivalents$49.8M-26.7%

Total debt$164.9M-4.1%

Total equity-$28.8M-336%

Total assets$220.6M+3.4%

Cash flow

See full

Operating cash flow-$10.0M+36.3%

CapEx$415.0K+30.1%

Free cash flow-$10.4M+35.0%

Valuation

See full

Market cap$470.86M-21.3%

Enterprise value$585.97M-16.6%

P/S1.6×-0.6×

Profitability

See full

Gross margin66.1%-2.4pp

Operating margin-13.7%-1.9pp

Net margin-14.4%-3.3pp

FCF margin-9.6%-3.6pp

Returns & leverage

See full

Return on equity-472.6%-1,534pp

Debt / equity22.2×—

Current ratio2×-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept eols:LicenseSupplyAndDistributionAgreementContingentMilestoneLiabilityCurrent.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's current portion of contingent milestone payment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evolus's current portion of contingent milestone payment?: Evolus (EOLS) reported current portion of contingent milestone payment of $1.3M in Q1 2026.
What does current portion of contingent milestone payment mean?: This represents the short-term portion of milestone payments due under license, supply, or distribution agreements, typically triggered by the achievement of specific commercial or regulatory goals. It indicates immediate cash obligations resulting from contractual partnerships necessary to bring products to market. Investors track this to understand the company's near-term capital commitments related to its strategic supply chain and distribution network.